Pre-clinical services from a top preclinical Contract Research Organization in Kiev, Ukraine.
We are an independent CRO operating out of the United States that conducts preclinical drug research in state-of-the art, Good Laboratory Practices certified research facilities in Kiev, Ukraine. Our testing sites are sponsored by the Ukrainian National Academy of Medical Sciences and Health Department and provide support for for-profit development of new medicine discoveries as part of their main mission. Our company was created to offer the top-notch, low-cost services of these research sites to new biotech companies in the USA and Europe, thereby offering a smart option for promoting development programs quickly and at much lower cost than other commercial CROs. We offer a broad range of pre-clinical research including drug safety, acute and chronic toxicity, pharma screening, bio-availability , bio-equivalence , and full in vitro and in vivo screening for anticancer activity.
Our pre-clinical Contract Research Organization is able to price preclinical services far below other CROs because we have a very low overhead in the USA and perform all trials in Kiev where personnel and facility costs are much lower. Our staff in the U.S. is comprised of only of the company principals who work directly with customers; we don’t have any marketing costs other than our site, and no main offices, supporting staff or other overhead to inflate costs. We have much lower trials conduct costs in Ukraine due to much lower labor rates and are happy to offer our most attractive pricing for longer and more complex preclinical studies where labor is the greatest portion of the overall cost. Since we utilize the same stable international suppliers for animal models, reagents and lab supplies as other CROs, we don’t have any cost savings on these items and thus less overall cost advantage for very short-term pre-clinical tests. However, regardless of your trial protocol and duration, our goal is to give our clients the best possible value for their money.